Gunnar Hillerdal

7.0k total citations · 1 hit paper
158 papers, 4.6k citations indexed

About

Gunnar Hillerdal is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Gunnar Hillerdal has authored 158 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Pulmonary and Respiratory Medicine, 22 papers in Surgery and 14 papers in Oncology. Recurrent topics in Gunnar Hillerdal's work include Occupational and environmental lung diseases (75 papers), Pleural and Pulmonary Diseases (62 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (25 papers). Gunnar Hillerdal is often cited by papers focused on Occupational and environmental lung diseases (75 papers), Pleural and Pulmonary Diseases (62 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (25 papers). Gunnar Hillerdal collaborates with scholars based in Sweden, Türkiye and United States. Gunnar Hillerdal's co-authors include Nõu E, Birgitta Schmekel, Kalevi Österman, Hirsh Koyi, Eva Brandén, Muzaffer Metintaş, Selma Metintaş, Kristina Lamberg, D.W. Henderson and Mustafa Özesmi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Gunnar Hillerdal

154 papers receiving 4.4k citations

Hit Papers

Guidelines of the European Respiratory Society and the Eu... 2009 2026 2014 2020 2009 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gunnar Hillerdal Sweden 33 3.7k 623 545 520 458 158 4.6k
Kevin O. Leslie United States 41 3.8k 1.0× 481 0.8× 1.1k 2.0× 446 0.9× 945 2.1× 147 5.7k
Joost Weyler Belgium 39 1.2k 0.3× 977 1.6× 630 1.2× 245 0.5× 634 1.4× 140 5.0k
Michaël C.G. Stevens United Kingdom 42 2.5k 0.7× 1.1k 1.8× 617 1.1× 841 1.6× 1.1k 2.4× 135 5.7k
David J. Ross United States 43 2.5k 0.7× 660 1.1× 475 0.9× 276 0.5× 2.6k 5.7× 177 6.0k
Tapio Vehmas Finland 33 1.5k 0.4× 136 0.2× 196 0.4× 319 0.6× 685 1.5× 142 3.7k
S. Donald Greenberg United States 27 1.7k 0.5× 477 0.8× 177 0.3× 183 0.4× 590 1.3× 117 2.7k
Edward A. Gaensler United States 35 3.9k 1.1× 119 0.2× 886 1.6× 395 0.8× 843 1.8× 93 4.8k
Isabelle Tillie‐Leblond France 38 2.3k 0.6× 165 0.3× 2.0k 3.7× 162 0.3× 355 0.8× 121 4.4k
Gen Suzuki Japan 37 830 0.2× 967 1.6× 312 0.6× 295 0.6× 950 2.1× 195 5.3k
Philippe Bonniaud France 34 2.5k 0.7× 500 0.8× 586 1.1× 182 0.3× 745 1.6× 134 4.8k

Countries citing papers authored by Gunnar Hillerdal

Since Specialization
Citations

This map shows the geographic impact of Gunnar Hillerdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Hillerdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Hillerdal more than expected).

Fields of papers citing papers by Gunnar Hillerdal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gunnar Hillerdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Hillerdal. The network helps show where Gunnar Hillerdal may publish in the future.

Co-authorship network of co-authors of Gunnar Hillerdal

This figure shows the co-authorship network connecting the top 25 collaborators of Gunnar Hillerdal. A scholar is included among the top collaborators of Gunnar Hillerdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunnar Hillerdal. Gunnar Hillerdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metintaş, Selma, Muzaffer Metintaş, Güntülü Ak, Gunnar Hillerdal, & Hirsh Koyi. (2021). Mesothelioma in immigrants from Turkey: Genes have a minor role. Respiratory Medicine. 186. 106527–106527. 1 indexed citations
2.
Hillerdal, Gunnar, Nõu E, Karin Österman, & Birgitta Schmekel. (2015). Sarcoidosis: Epidemiology and Prognosis. American Review of Respiratory Disease. 11 indexed citations
3.
Koyi, Hirsh & Gunnar Hillerdal. (2012). [Screening for lung cancer can save lives, according to US study. Too early for mass screening--but refer smokers to CT on broad indications].. PubMed. 109(5). 208–9.
4.
Hillerdal, Gunnar, et al.. (2011). One year follow-up of intrabronchial lung volume reduction in alpha-1-antitrypsin deficiency and severe emphysema. European Respiratory Journal. 38(Suppl 55). p3538–p3538. 1 indexed citations
5.
Metintaş, Muzaffer, Gunnar Hillerdal, Selma Metintaş, & Pascal Dumortier. (2010). Endemic Malignant Mesothelioma: Exposure to Erionite Is More Important Than Genetic Factors. Archives of Environmental & Occupational Health. 65(2). 86–93. 34 indexed citations
6.
Hillerdal, Gunnar. (2007). Yellow nail syndrome: treatment with octreotide. The Clinical Respiratory Journal. 1(2). 120–121. 17 indexed citations
7.
Guidotti, Tee L., Carl A. Brodkin, David C. Christiani, et al.. (2005). Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos. American Journal of Respiratory and Critical Care Medicine. 171(6). 666–667. 6 indexed citations
8.
Agrenius, V, et al.. (2004). Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive value. Respiratory Medicine. 98(12). 1166–1172. 14 indexed citations
9.
Koyi, Hirsh, et al.. (2002). The ‘reservoir’ of undetected bronchial carcinomas in the general population. Lung Cancer. 37(2). 137–142. 2 indexed citations
10.
Hillerdal, Gunnar, et al.. (2001). [Screening for lung cancer--new possibilities with new methods!].. PubMed. 98(17). 2047–51. 3 indexed citations
11.
Hillerdal, Gunnar. (1999). [Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer].. PubMed. 96(43). 4691–4691. 4 indexed citations
12.
Askling, Johan, Johan Grünewald, Anders Eklúnd, Gunnar Hillerdal, & Anders Ekbom. (1999). Increased Risk for Cancer Following Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 160(5). 1668–1672. 202 indexed citations
13.
Hillerdal, Gunnar, et al.. (1997). Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos. European Respiratory Journal. 10(12). 2711–2715. 10 indexed citations
14.
Hillerdal, Gunnar, et al.. (1991). [A man caused a miniepidemic of animal tuberculosis--he infected his wife and cat].. PubMed. 88(13). 1216–7. 1 indexed citations
15.
Hillerdal, Gunnar. (1989). Rounded Atelectasis. CHEST Journal. 95(4). 836–841. 66 indexed citations
16.
Järvholm, Bengt, et al.. (1986). Pleural plaques--asbestos--ill-health.. PubMed. 145. 1–59. 20 indexed citations
17.
Hillerdal, Gunnar, et al.. (1980). Radiologically visible pleural plaques in a one-year material from a health survey in 1976 a cross-sectional study.. PubMed. 107. 89–98. 7 indexed citations
18.
Hillerdal, Gunnar & Nõu E. (1979). Occupation and bronchial carcinoma.. PubMed. 60(2). 76–82. 9 indexed citations
19.
Hillerdal, Gunnar. (1978). Pleural plaques in a health survey material. Frequency, development and exposure to asbestos.. PubMed. 59(5). 257–63. 48 indexed citations
20.
Almgren, B, I Eriksson, A. Hemmingsson, et al.. (1978). Abdominal aortic aneurysm in homocystinuria.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 144(7-8). 545–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026